BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 241 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.25 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,532,396 | -30.7% | 2,758,813 | -31.1% | 0.06% | -32.1% |
| Q2 2023 | $28,193,088 | +6218.6% | 4,004,700 | +7385.4% | 0.08% | +8300.0% |
| Q1 2023 | $446,190 | -98.0% | 53,500 | -97.3% | 0.00% | -98.7% |
| Q4 2022 | $22,829,438 | +235.0% | 1,988,627 | +208.7% | 0.08% | +169.0% |
| Q2 2022 | $6,815,000 | +1847.1% | 644,100 | +2448.7% | 0.03% | +2800.0% |
| Q4 2021 | $350,000 | -88.1% | 25,272 | -87.6% | 0.00% | -92.3% |
| Q3 2021 | $2,930,000 | -87.8% | 203,913 | -93.7% | 0.01% | -88.9% |
| Q4 2020 | $24,069,000 | +1007.6% | 3,230,800 | +410.7% | 0.12% | +963.6% |
| Q3 2020 | $2,173,000 | -48.6% | 632,600 | -28.7% | 0.01% | -60.7% |
| Q2 2020 | $4,229,000 | -29.9% | 887,570 | -70.6% | 0.03% | -42.9% |
| Q1 2020 | $6,036,000 | -79.1% | 3,018,132 | -64.0% | 0.05% | -67.8% |
| Q4 2019 | $28,921,000 | +209.6% | 8,382,900 | +157.1% | 0.15% | +166.7% |
| Q3 2019 | $9,340,000 | +2319.7% | 3,260,000 | +6770.0% | 0.06% | +2750.0% |
| Q1 2019 | $386,000 | -86.3% | 47,453 | -86.4% | 0.00% | -85.7% |
| Q4 2018 | $2,825,000 | -38.4% | 350,000 | -62.5% | 0.01% | -30.0% |
| Q4 2017 | $4,585,000 | +15183.3% | 933,766 | +46588.3% | 0.02% | – |
| Q2 2015 | $30,000 | – | 2,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Burrage Capital Management LLC | 864,916 | $13,674,000 | 13.71% |
| Sarissa Capital Management LP | 4,261,000 | $67,366,000 | 5.36% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,920,733 | $30,367,000 | 4.18% |
| HealthCor Management, L.P. | 3,248,100 | $51,352,000 | 2.05% |
| Parkman Healthcare Partners LLC | 351,961 | $5,565,000 | 1.22% |
| Bain Capital Public Equity Management II, LLC | 1,560,730 | $24,675,000 | 1.06% |
| Baker Brothers Advisors | 12,710,818 | $200,958,000 | 0.88% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,835,000 | $44,821,000 | 0.80% |
| Biondo Investment Advisors, LLC | 265,840 | $4,203,000 | 0.72% |
| EAM Global Investors LLC | 157,065 | $2,483,000 | 0.69% |